Literature DB >> 914944

Quantitative analysis of d-tubocurarine chloride in curare by column liquid chromatography.

F P van der Maeden, P T van Rens, F A Buytenhuys, E Buurman.   

Abstract

An improved quantitative analysis of d-tubocurarine chloride in the plant extract curare is presented. Gradient high-performance liquid chromatography on a hydrophobic stationary phase was found to be very suitable for the analysis of quaternary ammonium bases such as the complex mixture of curare alkaloids. Owing to the residual free silanol groups on the modified silica surface, the curare alkaloids are eluted from a reversed-phase column only if an electrolyte is added to the mobile phase. In order to optimize the separation, the effects of pH, the nature of the cation in the buffer and the concentration of the buffer of the retention of the alkaloids were investigated. Using a tetramethylammonium phosphate buffer at pH 4 in a gradient of water-methanol, undesirable retardation effects on the reversed-phase column could be suppressed sufficiently. As a result, an accurate method for the determination of d-tubocurarine chloride in curare was obtained. The coefficient of variation of this analysis is only 1.3%.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 914944     DOI: 10.1016/s0021-9673(01)92079-5

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Quantitative determination of atracurium in human plasma using high-performance liquid chromatography.

Authors:  R Okutani; K Kono; F M DeBros; D M Philbin
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

Review 2.  Pharmacokinetics in intravenous anaesthetic practice.

Authors:  P Duvaldestin
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

3.  Chromatographic Characterization and Method Development for Determination of Levetiracetam in Saliva: Application to Correlation with Plasma Levels.

Authors:  Imad I Hamdan; Mervat Alsous; Amira Taher Masri
Journal:  J Anal Methods Chem       Date:  2017-08-07       Impact factor: 2.193

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.